Skip to main content
FinSpry Logo
FinSpry
FTH logo
FTH
(NASDAQ)
Faeth Therapeutics, Inc.
$27.76-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Faeth Therapeutics (FTH) Stock Price & Financial Analysis

Faeth Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$27.42 - $29.40
52-Week High$37.90
52-Week Low$6.33
Open$28.40
Volume100.73K
Average Volume (3M)199.17K
Market Cap35.95M
Shares Outstanding1.30M
Price to Book (P/B)0.19
EV/EBITDA0.62
Revenue (TTM)-4.85M
Net Income (TTM)-184.46M
Free Cash Flow (TTM)-24.11M
EPS (TTM)$-145.30
Return on Equity (ROE)-96.48%
Debt to Equity0.01
50-Day MA$21.49
200-Day MA$18.50
52-Week Change290.99%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Faeth Therapeutics

What is the current stock price for FTH?

As of the latest trading session, FTH stock trades at $27.76. The 52-week range is $6.33–$37.90, with a day range of $27.42–$29.40.

What is the P/E ratio for FTH?

The P/E ratio (Price-to-Earnings) for FTH is shown in the Key Statistics section. This valuation metric helps compare Faeth Therapeutics, Inc. to industry peers.

Does FTH pay dividends?

Faeth Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for FTH?

Based on 6 analysts, the consensus for FTH is Buy.

What is the market cap of FTH?

Faeth Therapeutics's market capitalization is $36.0M, classifying it as a micro-cap company. Faeth Therapeutics operates in the Healthcare sector within the Biotechnology industry.